Lawson Kroeker Investment Management Inc. NE Reduces Holdings in HCA Healthcare, Inc. $HCA

Lawson Kroeker Investment Management Inc. NE trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 52,465 shares of the company’s stock after selling 232 shares during the period. HCA Healthcare comprises approximately 3.7% of Lawson Kroeker Investment Management Inc. NE’s investment portfolio, making the stock its 6th largest holding. Lawson Kroeker Investment Management Inc. NE’s holdings in HCA Healthcare were worth $20,099,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. ORG Partners LLC grew its holdings in HCA Healthcare by 27.9% during the second quarter. ORG Partners LLC now owns 142 shares of the company’s stock valued at $55,000 after purchasing an additional 31 shares during the period. Avantax Advisory Services Inc. increased its holdings in HCA Healthcare by 0.4% in the 1st quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company’s stock worth $2,791,000 after acquiring an additional 32 shares during the last quarter. Glenview Trust co boosted its position in HCA Healthcare by 2.3% during the first quarter. Glenview Trust co now owns 1,451 shares of the company’s stock worth $501,000 after purchasing an additional 32 shares during the period. Horizon Investments LLC raised its position in shares of HCA Healthcare by 1.1% in the first quarter. Horizon Investments LLC now owns 3,175 shares of the company’s stock valued at $1,097,000 after purchasing an additional 33 shares during the period. Finally, Sivia Capital Partners LLC raised its holdings in HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after acquiring an additional 33 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares in the company, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.30% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. Robert W. Baird boosted their price objective on HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a research note on Thursday, August 14th. Morgan Stanley lowered their price target on shares of HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating on the stock in a report on Monday, July 28th. Wolfe Research lowered shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a report on Monday, July 28th. KeyCorp boosted their price target on shares of HCA Healthcare from $370.00 to $465.00 and gave the company an “overweight” rating in a research report on Wednesday. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $444.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 7th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $422.31.

HCA Healthcare Stock Performance

Shares of NYSE:HCA opened at $414.73 on Friday. The firm has a fifty day moving average of $405.12 and a 200 day moving average of $375.85. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $439.01. The firm has a market capitalization of $97.04 billion, a PE ratio of 17.43, a price-to-earnings-growth ratio of 1.31 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to analysts’ expectations of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period in the prior year, the business earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.